» Articles » PMID: 33847825

The Involvement of MicroRNAs in SARS-CoV-2 Infection Comorbid with HIV-Associated Preeclampsia

Overview
Date 2021 Apr 13
PMID 33847825
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: This review investigated the potential role of microRNAs (miRNAs) in the synergy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, preeclampsia (PE), and human immunodeficiency virus (HIV) infection. Maternal health is a great concern when treating pregnant women fighting this triad of diseases, which is highly prevalent in South Africa. MicroRNAs are involved in fine-tuning of physiological processes. Disruptions to the balance of this minute protein can lead to various physiological changes that are sometimes pathological.

Recent Findings: MicroRNAs have recently been implicated in PE and have been linked to the anti-angiogenic imbalance evident in PE. Recent in silico studies have identified potential host miRNAs with anti-viral properties against SARS-CoV-2 infection. Studies have demonstrated dysregulated expression of several miRNAs in HIV-1 infection along with the ability of HIV-1 to downregulate anti-viral host microRNAs. This review has highlighted the significant gap in literature on the potential of miRNAs in women with HIV-associated PE in synergy with the novel SARS-CoV-2 infection. In addition, this review has provided evidence of the critical role that the epigenetic regulatory mechanism of miRNA plays in viral infections and PE, thereby providing a foundation for further research investigating the potential of therapeutic miRNA development with fewer side-effects for pregnant women.

Citing Articles

MicroRNA-29 differentially mediates preeclampsia-dysregulated cellular responses to cytokines in female and male fetal endothelial cells.

Zhou C, Freel C, Mills O, Yang X, Yan Q, Zheng J J Physiol. 2023; 601(16):3631-3645.

PMID: 37401732 PMC: 10807859. DOI: 10.1113/JP284746.


miRNAs as a Potential Biomarker in the COVID-19 Infection and Complications Course, Severity, and Outcome.

Jankovic M, Nikolic D, Novakovic I, Petrovic B, Lackovic M, Santric-Milicevic M Diagnostics (Basel). 2023; 13(6).

PMID: 36980399 PMC: 10047241. DOI: 10.3390/diagnostics13061091.


Vascular Endothelial Growth Factor Receptor 2: Molecular Mechanism and Therapeutic Potential in Preeclampsia Comorbidity with Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections.

Abel T, Moodley J, Khaliq O, Naicker T Int J Mol Sci. 2022; 23(22).

PMID: 36430232 PMC: 9691176. DOI: 10.3390/ijms232213752.


Neuropilin-1 in the pathogenesis of preeclampsia, HIV-1, and SARS-CoV-2 infection: A review.

Naidoo N, Moodley J, Khaliq O, Naicker T Virus Res. 2022; 319:198880.

PMID: 35905790 PMC: 9316720. DOI: 10.1016/j.virusres.2022.198880.


MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies.

Panda M, Kalita E, Singh S, Kumar K, Rao A, Prajapati V Life Sci. 2022; 305:120761.

PMID: 35787998 PMC: 9249409. DOI: 10.1016/j.lfs.2022.120761.


References
1.
Inchley C, Sonerud T, Fjaerli H, Nakstad B . Nasal mucosal microRNA expression in children with respiratory syncytial virus infection. BMC Infect Dis. 2015; 15:150. PMC: 4387708. DOI: 10.1186/s12879-015-0878-z. View

2.
Tikellis C, Johnston C, Forbes J, Burns W, Burrell L, Risvanis J . Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension. 2003; 41(3):392-7. DOI: 10.1161/01.HYP.0000060689.38912.CB. View

3.
Sebitloane H, Moodley J, Sartorius B . Associations between HIV, highly active anti-retroviral therapy, and hypertensive disorders of pregnancy among maternal deaths in South Africa 2011-2013. Int J Gynaecol Obstet. 2017; 136(2):195-199. DOI: 10.1002/ijgo.12038. View

4.
Mol B, Roberts C, Thangaratinam S, Magee L, de Groot C, Hofmeyr G . Pre-eclampsia. Lancet. 2015; 387(10022):999-1011. DOI: 10.1016/S0140-6736(15)00070-7. View

5.
Jones D, Baluja M, Graham D, Corbishley A, McDonald J, Malham S . Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19. Sci Total Environ. 2020; 749:141364. PMC: 7836549. DOI: 10.1016/j.scitotenv.2020.141364. View